SEC Form 4 · accession 0001645627-18-000002
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 2, 2018
Accepted (ET)
Jan 8, 2018 · 1:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | P | 2,000 | $0.0653 | A | 24,686,189 | D | |
| Common Stock | Jan 2, 2018 | P | 2,000 | $0.063 | A | 24,688,189 | D | |
| Common Stock | Jan 2, 2018 | P | 1,000 | $0.0615 | A | 24,689,189 | D | |
| Common Stock | Jan 3, 2018 | P | 3,000 | $0.0598 | A | 24,692,189 | D | |
| Common Stock | Jan 4, 2018 | P | 3,000 | $0.059 | A | 24,695,189 | D | |
| Common Stock | Jan 5, 2018 | P | 3,000 | $0.0584 | A | 24,698,189 | D |
Table II — derivative securities
No Table II lines on this filing.